涛生医药 (839411.OC)

+ 收藏

现金流量表(涛生医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 76,298,299.7299,861,706.3041,707,068.18120,051,035.9159,457,970.28
 收到的税费返还(元) 881,042.88500,715.38-2,566,169.171,004,052.93
 收到其他与经营活动有关的现金(元) 6,813,770.8338,094,548.4930,598,281.0419,254,290.652,732,923.29
 经营活动现金流入小计(元) 83,993,113.43138,456,970.1772,305,349.22141,871,495.7363,194,946.50
 购买商品、接受劳务支付的现金(元) 62,112,410.2478,853,540.0032,016,755.1582,496,412.4339,574,560.48
 支付给职工以及为职工支付的现金(元) 4,610,338.5910,146,134.445,739,883.9913,071,136.256,638,446.53
 支付的各项税费(元) 647,928.111,058,243.11615,313.602,275,190.411,147,228.38
 支付其他与经营活动有关的现金(元) 7,015,387.7143,406,532.9911,161,115.4426,410,142.5210,455,499.34
 经营活动现金流出小计(元) 74,386,064.65133,464,450.5449,533,068.18124,252,881.6157,815,734.73
 经营活动产生的现金流量净额(元) 9,607,048.784,992,519.6322,772,281.0417,618,614.125,379,211.77
二、投资活动产生的现金流量
 收回投资收到的现金(元) ---1,018,068.52--
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 48,400.00----
 处置子公司及其他营业单位收到的现金净额(元) ---1,470,000.00670,000.00
 投资活动现金流入小计(元) 48,400.00--1,018,068.521,470,000.00670,000.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 17,840,500.2046,220,198.4626,342,896.0223,266,695.593,432,263.06
 支付其他与投资活动有关的现金(元) -818,068.52---
 投资活动现金流出小计(元) 17,840,500.2047,038,266.9826,342,896.0223,266,695.593,432,263.06
 投资活动产生的现金流量净额(元) -17,792,100.20-47,038,266.98-27,360,964.54-21,796,695.59-2,762,263.06
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) -16,116,133.14-13,045,041.65-
  其中:子公司吸收少数股东投资收到的现金(元) -16,116,133.14-13,045,041.65-
 取得借款收到的现金(元) 21,700,000.0062,738,958.8929,488,958.8928,558,426.7110,568,537.99
 收到其他与筹资活动有关的现金(元) 4,999,252.005,474,020.23-650,705.44-
 筹资活动现金流入小计(元) 26,699,252.0084,329,112.2629,488,958.8942,254,173.8010,568,537.99
 偿还债务支付的现金(元) 16,307,785.7244,511,403.3219,464,774.4431,239,690.5114,022,073.14
 分配股利、利润或偿付利息支付的现金(元) 1,446,674.872,373,434.681,116,528.432,307,385.391,048,996.39
 支付其他与筹资活动有关的现金(元) 603,200.00676,040.53938,565.431,626,534.7553,614.42
 筹资活动现金流出小计(元) 18,357,660.5947,560,878.5321,519,868.3035,173,610.6515,124,683.95
 筹资活动产生的现金流量净额(元) 8,341,591.4136,768,233.737,969,090.597,080,563.15-4,556,145.96
五、现金及现金等价物净增加额(元) 156,539.99-5,277,513.623,380,407.092,902,481.68-1,939,197.25
 加:期初现金及现金等价物余额(元) 6,176,436.5111,453,950.1311,453,950.138,551,468.458,551,468.45
 期末现金及现金等价物余额(元) 6,332,976.506,176,436.5114,834,357.2211,453,950.136,612,271.20
补充资料:
 净利润(元) --5,882,065.161,347,392.30-22,215,173.68-9,808,173.08
 资产减值准备(元) -924,809.54-1,217,055.681,771,737.59271,704.30
 固定资产和投资性房地产折旧(元) -1,909,336.261,013,911.672,154,024.981,079,187.04
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) -1,909,336.261,013,911.672,154,024.981,079,187.04
 无形资产摊销(元) -770,444.81535,689.71564,313.93263,324.35
 长期待摊费用摊销(元) -294,111.68184,657.52426,282.93203,699.32
 固定资产报废损失(元) ---4,367.003,543.68
 财务费用(元) -2,436,528.021,175,159.812,381,522.441,183,468.88
 投资损失(元) --5,754,601.80-6,150,418.07--
 递延所得税(元) -910,836.13-161,568.23-606,715.57-115,894.31
  其中:递延所得税资产减少(元) -831,092.11-161,568.23-606,715.57-115,894.31
 递延所得税负债增加(元) -79,744.02---
 存货的减少(元) -1,042,259.07276,554.64426,110.811,145,518.30
 经营性应收项目的减少(元) -3,810,086.2410,795,512.6322,541,329.9618,190,745.30
 经营性应付项目的增加(元) -3,179,604.3613,906,316.117,667,907.67-5,262,078.98
 其他(元) -----3,250,254.89
 现金的期末余额(元) -6,176,436.5114,834,357.2211,453,950.136,612,271.20
 减:现金的期初余额(元) -11,453,950.1311,453,950.138,551,468.458,551,468.45
 现金及现金等价物的净增加额(元) --5,277,513.623,380,407.092,902,481.68-1,939,197.25
公告日期 2024-08-292024-04-242023-08-282023-04-142022-08-24
审计意见(境内) 带强调事项段的无保留意见带强调事项段的无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院